Radiofrequency Enhanced Cosmetic Composition Delivery

Publication ID: 24-11857748_0002_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Radiofrequency Enhanced Cosmetic Composition Delivery,” Published Technical Disclosure No. 24-11857748_0002_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857748_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,748.

Summary of the Inventive Concept

This inventive concept leverages the core technology of the original patent to develop novel systems and methods for enhanced delivery of cosmetic compositions to skin regions, promoting skin rejuvenation, hair growth, and acne treatment.

Background and Problem Solved

Current cosmetic treatments often rely on topical creams or invasive procedures, which may have limited efficacy or cause unwanted side effects. The original patent's technology, initially designed for treating occlusions in blood vessels, can be adapted to address these limitations in the cosmetic industry.

Detailed Description of the Inventive Concept

The inventive concept utilizes radiofrequency energy to enhance the delivery of cosmetic compositions, such as therapeutic agents, pharmaceutical compounds, or skin rejuvenation formulas, to specific skin regions. The system comprises a radiofrequency energy source and a composition delivery element, which can be configured to target various skin concerns, including acne, hair loss, and hyperpigmentation. The method involves directing the radiofrequency energy source to the skin region and providing the cosmetic composition, allowing for controlled and prolonged delivery.

Novelty and Inventive Step

The inventive concept introduces a new application of the original patent's technology, shifting from treating occlusions in blood vessels to enhancing cosmetic composition delivery in the skin. This adaptation constitutes a non-obvious and novel use of the core technology.

Alternative Embodiments and Variations

Alternative embodiments may include varying the type of radiofrequency energy, adjusting the composition delivery element's design, or incorporating additional features, such as temperature control or sensing mechanisms, to optimize the system's performance. Variations could also involve using different cosmetic compositions or targeting specific skin conditions, such as rosacea or psoriasis.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the cosmetic industry, with applications in skincare, hair care, and dermatology. The target market includes cosmetic companies, dermatology clinics, and medical spas, with potential for expansion into the consumer market.

CPC Classifications

SectionClassGroup
A A61 A61M37/00
A A61 A61B17/22
A A61 A61N1/306
A A61 A61N1/40
A A61 A61N1/44
A A61 A61B18/14
A A61 A61B2017/22001
A A61 A61B2017/22005
A A61 A61B2017/22084
A A61 A61B2018/0022
A A61 A61K9/0009
A A61 A61M25/104
A A61 A61M2025/0057
A A61 A61M2025/105
A A61 A61M2037/0007
A A61 A61N1/327

Field of Art

Medical device technologies and energy-based therapeutic delivery systems, specifically involving radiofrequency energy for targeted composition delivery across biological tissues

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in energy-based medical interventions, familiar with radiofrequency technologies, tissue interaction principles, and cross-domain application of energy-assisted delivery techniques

Obviousness Rationale

A PHOSITA would recognize that the core radiofrequency energy delivery mechanism disclosed in the source patent represents a generalizable technique for enhancing composition penetration across biological tissues. The fundamental principles of using radiofrequency energy to modulate tissue permeability and facilitate targeted delivery are directly transferable between medical and cosmetic applications. The PTD demonstrates a predictable extension of the original patent's core technological concept by applying the same energy-based delivery mechanism to different tissue types and compositional goals.

Obvious Combinations & Variations

Source Patent Element
Radiofrequency energy applied to biological tissues for composition delivery
PTD Variation
Redirecting radiofrequency energy delivery from blood vessels to skin regions for cosmetic composition penetration
Obviousness Reasoning
Known technique of adapting energy-based medical delivery principles to adjacent therapeutic domains with predictable results
Source Patent Element
Targeted delivery of therapeutic agents using energy modulation
PTD Variation
Expanding agent types from vascular pharmaceuticals to cosmetic and dermatological compositions
Obviousness Reasoning
Finite set of known composition types with established permeability challenges that would benefit from energy-assisted delivery
Source Patent Element
Electrode-based radiofrequency energy application
PTD Variation
Modifying electrode configuration for skin-specific composition delivery targeting
Obviousness Reasoning
Design choice involving routine engineering adaptation of existing technological principles
Source Patent Element
Method for enhancing composition penetration through tissue
PTD Variation
Expanding treatment targets from occlusion management to cosmetic concerns like acne and hair growth
Obviousness Reasoning
Predictable extension of energy-based delivery technique to alternative physiological improvement goals
35 U.S.C. § 103 Summary: Based on US Patent 11857748's disclosure of radiofrequency-enabled composition delivery, the present publication demonstrates that variations involving cosmetic and dermatological applications represent obvious technological extensions obvious to a person having ordinary skill in medical energy delivery technologies. The disclosed methods constitute prior art rendering obvious any subsequent claims attempting to monopolize energy-assisted composition delivery across skin treatment domains.

Original Patent Information

Patent NumberUS 11,857,748
TitleMethod and device for enhanced composition delivery
Assignee(s)ASAHI MEDICAL TECHNOLOGIES, INC.